NXS 3.33% 29.0¢ next science limited

Almost every sml med cap that is not paying a healthy dividend...

  1. 261 Posts.
    Almost every sml med cap that is not paying a healthy dividend has been hammered down in the past 6 mths this is a phenomenon that is across the board.
    The speculative market is simply unloved regardless of their assets.
    It is difficult to see any recovery in the NXS sp in the short to medium term regardless of any progress the board may make.
    NXS if it survives has planed for its next growth phase through 2014-2015 with additional wells and gas from longtom. With this in mind there is no obvious catalyst to trigger a SP revival at present.
    Sadly they have missed the CRUX boat and flogged off a large portion of a valuable asset for the bargain price of 75mil.
    In addition there is no urgency required from shell to move CRUX forward they can simply wait for global markets to improve, dictate the terms, and proceed at a time that suits them.
    The NXS board is stuck between a rock and a hard place with dwindelling cash reserves, and a long tom asset that has traditionally been unreliable.
    The question is simple "Why would you buy into this company in this current economic climate?
    This company sits at 8c because given the current and previous boards poor management skills, and incompitant decision making 8cents is all the dog of a thing is worth.
    My opinion only.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
29.0¢
Change
-0.010(3.33%)
Mkt cap ! $81.67M
Open High Low Value Volume
30.0¢ 30.0¢ 28.0¢ $20.33K 70.82K

Buyers (Bids)

No. Vol. Price($)
1 2300 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 9877 2
View Market Depth
Last trade - 11.31am 25/07/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.